• 65% decreased risk after taking hormone-blocking pill source

• » A huge step forward: The study, which involved 4,500 people, represents progress towards a safe-to-take drug that prevents breast cancer in at-risk patients. While anti-estrogen drugs already exist on the market, they’ve had pretty horrific side effects that discourage their use. So far, aromatase inhibitors don’t have any of these side effects — but it’s important to note that there haven’t been long-term studies with this, either. (This is the first time researchers tested an aromatase inhibitor tested clinically.) However, it’s still encouraging and worth keeping an eye on.

Posted by Justin Jones • Permalink